Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Fasudil decreases lesion burden in a murine model of cerebral cavernous malformation disease.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Fasudil decreases lesion burden in a murine model of cerebral cavernous malformation disease.
Fasudil decreases lesion burden in a murine model of cerebral cavernous malformation disease. Stroke. 2012 Feb; 43(2):571-4.
View in:
PubMed
subject areas
1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine
Animals
Brain
Cerebral Hemorrhage
Enzyme Inhibitors
Inflammation
Intracranial Arteriovenous Malformations
KRIT1 Protein
Mice
Mice, Knockout
Microtubule-Associated Proteins
MutS Homolog 2 Protein
Phenotype
Proto-Oncogene Proteins
rho-Associated Kinases
Tumor Suppressor Protein p53
Vasodilator Agents
authors with profiles
Issam Awad
Robert Shenkar